1. These Regulations may be cited as the Misuse of Drugs (Amendment No.2) Regulations (Northern Ireland) 2012 and shall come into operation on 13th June 2012.
2. The Interpretation Act (Northern Ireland) 1954(1) shall apply to these Regulations as it applies to an Act of the Assembly
3. The Misuse of Drugs Regulations (Northern Ireland) 2002(2) shall be amended as follows.
4. In Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27) after paragraph 1(n), insert—
“(o)Any compound (not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say,
(i)by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups;
(ii)by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group;
(iii)by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.”.
5. In paragraph 1(a) of Schedule 3 (which specifies controlled drugs subject to the requirements of regulations 14, 15 (except Temazepam), 16, 18, 22, 23, 24, 26 and 27) after “Benzphetamine”, insert “7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one”.
6. In Schedule 3 for paragraphs 2, 3 and 4, substitute—
“2. Any stereoisomeric form of a substance specified in paragraph 1 or 3 not being phenylpropanolamine.
3. Any ester or ether of pipradrol.
4. Any salt of a substance specified in any of paragraphs 1 to 3.
5. Any preparation or other product containing a substance specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 5.”.
Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 22nd May 2012
(L.S.)
Norman Morrow
A senior officer of the Department of Health, Social Services and Public Safety